Kingsman Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.21M Buy
3,635
+802
+28% +$946K 1.88% 18
2026
Q2
$3.4M Buy
2,833
+923
+48% +$943K 1.59% 17
2026
Q1
$1.76M Buy
1,910
+130
+7% +$132K 0.99% 24
2025
Q4
$1.91M Buy
1,780
+1,243
+231% +$1.19M 1.03% 20
2025
Q3
$410K Sell
537
-879
-62% -$654K 0.23% 49
2025
Q2
$1.1M Sell
1,416
-645
-31% -$501K 0.69% 23
2025
Q1
$1.7M Buy
+2,061
New +$1.71M 1.24% 19

Other funds holding LLY

Kingsman Wealth Management's LLY Position: Q3 2026 in Review

Kingsman Wealth Management increased its Eli Lilly (LLY) stake by 28% in Q3 2026, buying an estimated $946K and bringing the position to 3,635 shares worth $4.21M. The position accounts for 1.88% of the portfolio, ranked #18.

Kingsman Wealth Management first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Kingsman Wealth Management held 3,635 shares of Eli Lilly worth $4.21M as of Q3 2026.
  • Kingsman Wealth Management bought 802 Eli Lilly shares in Q3 2026, an estimated $946K.
  • Eli Lilly made up 1.88% of Kingsman Wealth Management's portfolio in Q3 2026, its #18 holding.
  • Kingsman Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Kingsman Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.